MIA anticorps (Biotin)
Aperçu rapide pour MIA anticorps (Biotin) (ABIN181669)
Antigène
Voir toutes MIA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- This antibody detects MIA.
-
Purification
- Affinity Chromatography.
-
Immunogène
- Highly pure (> 98%) recombinant Human MIA
-
-
-
-
Indications d'application
-
Direct ELISA: To detect Human MIA (using 100 μL/well antibody solution) a concentration ofapprox. 1.0 μg/mL of this antibody is required. It allows the detection of at least 0.2-0.4 ng/well ofrecombinant Human MIA. Sandwich ELISA: To detect Human MIA (using 100 μL/well antibody solution) aconcentration of 0.25-1.0 μg/mL of this antibody is required. In conjunction with PolyclonalAnti-Human MIA (ABIN181672 or ABIN181671) as a Capture antibody, it allows thedetection of at least 0.2-0.4 ng/well of recombinant Human MIA. Western blot: To detect Human MIA by Western Blot analysis this antibody can be used ata concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagentsthe detection limit for recombinant Human MIA is 1.5-3.0 ng/lane, under either reducing ornon-reducing conditions.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Centrifuge vial prior to opening. Restore in sterile PBS containing 0.1 % BSA to a concentration of 0.1 - 1.0 mg/mL.
-
Buffer
- PBS, pH 7.2 without preservatives.
-
Agent conservateur
- Without preservative
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the lyophilized antibody at -20 °C. Following reconstitution it is stable for two weeks at 2-8 °C. Frozen aliquots are stable for 6 months when stored at -20 °C.
-
Date de péremption
- 6 months
-
-
- MIA (Melanoma Inhibitory Activity (MIA))
-
Autre désignation
- MIA
-
Sujet
- Melanoma Inhibitory Activity (MIA) was originally identified as an inhibitor of the in vitro growth of malignant melanoma cells. It was the first discovered member of a family of secreted cytokines termed the MIA/OTOR family. The four known members of this family, Melanoma Inhibitory Activity, MIA2, OTOR and TANGO each contain a Src homology-3 (SH3)-like domain. Melanoma Inhibitory Activity is an autocrine growth regulatory protein secreted from chondrocytes and malignant melanoma cells that promotes melanoma metastasis by binding competitively to fibronectin and laminin in a manner that results in melanoma cell detachment from the extracellular matrix in vivo. Elevated levels of Melanoma Inhibitory Activity may represent a clinically useful marker for diagnosis of melanoma metastasis as well as a potential marker for rheumatoid arthritis.Synonyms: Melanoma inhibitory activity, Melanoma-derived growth regulatory protein
-
ID gène
- 8190
-
NCBI Accession
- NP_001189482
-
UniProt
- Q16674
Antigène
-